MAPT and Alzheimer disease: We also evaluate the protective effects of vanadium compounds, the anti-diabetes agents, on AD treatment and discuss the underlying mechanisms of these agents, as well as the limitation of current studies in this field by searching for keywords in pairs, including APP and glucose/insulin, tau and glucose/insulin, vanadium and glucose/insulin, Alzheimer’s disease and vanadium on Pubmed.